PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24038215-7	2014	In cells treated with phorbol-12-myristate-13-acetate (PMA), apo A-I gene promoter activity was inhibited and apo A-I mRNA content and apo A-I protein secretion decreased.	Tetradecanoylphorbol Acetate	22-53	apolipoprotein A1	Homo sapiens	61-68	
31335245-1	2019	Context: We reported that D-4F, an apolipoprotein A-I (Apo A-I) mimetic polypeptide with 18 d-amino acids, suppressed IL-4 induced macrophage alternative activation and TGF-beta1 expression in phorbol 12-myristate 13-acetate (PMA) treated human acute monocytic leukemia cells (THP-1).	Tetradecanoylphorbol Acetate	193-224	apolipoprotein A1	Homo sapiens	55-62	
31335245-1	2019	Context: We reported that D-4F, an apolipoprotein A-I (Apo A-I) mimetic polypeptide with 18 d-amino acids, suppressed IL-4 induced macrophage alternative activation and TGF-beta1 expression in phorbol 12-myristate 13-acetate (PMA) treated human acute monocytic leukemia cells (THP-1).	Tetradecanoylphorbol Acetate	226-229	apolipoprotein A1	Homo sapiens	55-62	
28105139-4	2016	Phorbol 12-myristate 13-acetate-stimulated THP-1 cells were treated with oxidized low-density lipoprotein and (3H)-cholesterol for 24 h, and the effects of baicalin on cholesterol efflux were evaluated in the presence of apolipoprotein A-1 (ApoA-1), or high-density lipoprotein subfraction 2 (HDL2) or subfraction 3 (HDL3).	Tetradecanoylphorbol Acetate	0-31	apolipoprotein A1	Homo sapiens	221-239	
28105139-4	2016	Phorbol 12-myristate 13-acetate-stimulated THP-1 cells were treated with oxidized low-density lipoprotein and (3H)-cholesterol for 24 h, and the effects of baicalin on cholesterol efflux were evaluated in the presence of apolipoprotein A-1 (ApoA-1), or high-density lipoprotein subfraction 2 (HDL2) or subfraction 3 (HDL3).	Tetradecanoylphorbol Acetate	0-31	apolipoprotein A1	Homo sapiens	241-247	
24038215-7	2014	In cells treated with phorbol-12-myristate-13-acetate (PMA), apo A-I gene promoter activity was inhibited and apo A-I mRNA content and apo A-I protein secretion decreased.	Tetradecanoylphorbol Acetate	22-53	apolipoprotein A1	Homo sapiens	110-117	
24038215-7	2014	In cells treated with phorbol-12-myristate-13-acetate (PMA), apo A-I gene promoter activity was inhibited and apo A-I mRNA content and apo A-I protein secretion decreased.	Tetradecanoylphorbol Acetate	22-53	apolipoprotein A1	Homo sapiens	110-117	
24038215-7	2014	In cells treated with phorbol-12-myristate-13-acetate (PMA), apo A-I gene promoter activity was inhibited and apo A-I mRNA content and apo A-I protein secretion decreased.	Tetradecanoylphorbol Acetate	55-58	apolipoprotein A1	Homo sapiens	61-68	
24038215-7	2014	In cells treated with phorbol-12-myristate-13-acetate (PMA), apo A-I gene promoter activity was inhibited and apo A-I mRNA content and apo A-I protein secretion decreased.	Tetradecanoylphorbol Acetate	55-58	apolipoprotein A1	Homo sapiens	110-117	
24038215-7	2014	In cells treated with phorbol-12-myristate-13-acetate (PMA), apo A-I gene promoter activity was inhibited and apo A-I mRNA content and apo A-I protein secretion decreased.	Tetradecanoylphorbol Acetate	55-58	apolipoprotein A1	Homo sapiens	110-117	
9806357-5	1998	Activation of PKC by phorbol myristate acetate (PMA) stimulated MAP kinase activity, and down-regulation of PKC completely prevented apo A-I-stimulation of MAP kinase activity.	Tetradecanoylphorbol Acetate	48-51	apolipoprotein A1	Homo sapiens	133-140	
16607034-6	2006	Dibutyryl cyclic AMP and phorbol 12-myristate 13-acetate, which differentiate apoA-I-mediated cellular lipid release between 293/2c and 293/6c, also exhibited the same differential effects on the SAA-mediated reactions.	Tetradecanoylphorbol Acetate	25-56	apolipoprotein A1	Homo sapiens	78-84	
14570867-7	2004	Expression of ABCA1-GFP- and apoA-I-mediated lipid release were enhanced in parallel by phorbol 12-myristate 13-acetate (PMA) in 293/2c cells.	Tetradecanoylphorbol Acetate	88-119	apolipoprotein A1	Homo sapiens	29-35	
14570867-7	2004	Expression of ABCA1-GFP- and apoA-I-mediated lipid release were enhanced in parallel by phorbol 12-myristate 13-acetate (PMA) in 293/2c cells.	Tetradecanoylphorbol Acetate	121-124	apolipoprotein A1	Homo sapiens	29-35	
8521977-1	1995	The regulation of apolipoprotein A-I (apo A-I) gene expression by 12-O-tetradecanoylphorbol 13-acetate (TPA) was investigated in the human hepatoma cell line Hep G2.	Tetradecanoylphorbol Acetate	66-102	apolipoprotein A1	Homo sapiens	18-36	
8521977-1	1995	The regulation of apolipoprotein A-I (apo A-I) gene expression by 12-O-tetradecanoylphorbol 13-acetate (TPA) was investigated in the human hepatoma cell line Hep G2.	Tetradecanoylphorbol Acetate	66-102	apolipoprotein A1	Homo sapiens	38-45	
8521977-1	1995	The regulation of apolipoprotein A-I (apo A-I) gene expression by 12-O-tetradecanoylphorbol 13-acetate (TPA) was investigated in the human hepatoma cell line Hep G2.	Tetradecanoylphorbol Acetate	104-107	apolipoprotein A1	Homo sapiens	18-36	
8521977-1	1995	The regulation of apolipoprotein A-I (apo A-I) gene expression by 12-O-tetradecanoylphorbol 13-acetate (TPA) was investigated in the human hepatoma cell line Hep G2.	Tetradecanoylphorbol Acetate	104-107	apolipoprotein A1	Homo sapiens	38-45	
8521977-2	1995	TPA treatment decreased apo A-I mRNA levels in a time-dependent manner, by up to 50% versus control cells within 24 h. Nuclear run-on transcription assays demonstrated a transcriptional effect of TPA.	Tetradecanoylphorbol Acetate	0-3	apolipoprotein A1	Homo sapiens	24-31	
8521977-2	1995	TPA treatment decreased apo A-I mRNA levels in a time-dependent manner, by up to 50% versus control cells within 24 h. Nuclear run-on transcription assays demonstrated a transcriptional effect of TPA.	Tetradecanoylphorbol Acetate	196-199	apolipoprotein A1	Homo sapiens	24-31	
8521977-3	1995	Using transfection analysis with a plasmid construct containing the -1378/+11 apo A-I promoter fused to the secreted placental alkaline phosphatase (SPAP) reporter gene, we showed that the SPAP activity was decreased to 50% when Hep G2 cells were incubated in the presence of TPA.	Tetradecanoylphorbol Acetate	276-279	apolipoprotein A1	Homo sapiens	78-85	
8521977-4	1995	The inhibitory effect of TPA was still maintained when fragment -253 to -4 of apo A-I promoter was linked to the CAT reporter gene.	Tetradecanoylphorbol Acetate	25-28	apolipoprotein A1	Homo sapiens	78-85